Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Imunoflazid Light
- Development stage
- Unknown
- Lead developer
- PhytoHealth
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Imunoflazid Light is an over-the-counter herbal dietary supplement syrup developed and manufactured by the Ukrainian pharmaceutical company Ecopharm. It is formulated as a syrup containing a liquid extract mixture of two wild grasses: tufted hair grass (*Deschampsia caespitosa*) and bush grass (*Calamagrostis epigeios*), collectively known as Proteflazid. The active flavonoid components of these extracts are reported to possess antiviral, antioxidant, and immunomodulatory properties. Imunoflazid Light is marketed to support the normal functioning of the immune system and to strengthen the body's resistance to viral and bacterial respiratory infections, particularly in adults and children aged 3 years and older.
- Brand names
- Immunoflazid LightImunoflazid LightІмунофлазід Лайт
- Other names
- Calamagrostis epigeios extract + Deschampsia caespitosa extractDeschampsia caespitosa extract + Calamagrostis epigeios extractProteflazidProteflazidum
02
Targets
CASP9 (Caspase-9)NeuraminidaseIFN-α (Interferon alpha-7)IFNG (Interferon gamma)NFE2L2 (Nuclear factor (erythroid-derived 2)-like 2)Human immunodeficiency virus type 1 reverse transcriptaseHSV-TK (Herpes simplex virus type 1 thymidine kinase (HSV1-TK))Mpro (3C-like proteinase of SARS-CoV-2)DNA polymerase familyRNAP (Bacterial dna-dependent RNA polymerase)TK2 (Thymidine kinase 2)
Beyond the preview
Go deeper on Imunoflazid Light.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Imunoflazid Light.